Our integrative analysis of miRNA-mRNA expression data predicted new potential targets of miR-125b, namely RASGRF2 and CYSLTR2. Low expression of RASGRF2 has been described in lymphoma, lung cancer, cancer cell lines and primary tumour but not in MM (Chen et al. 2006). Here, CYSLTR2 is linked to Miyoshi myopathy.